New knee gel injection aims to ease arthritis pain
NCT ID NCT05337540
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a single injection of EVI-01, a hyaluronic acid gel, in 120 people with painful knee osteoarthritis. The goal was to find the best dose that reduces pain and improves function while being safe. Participants were randomly assigned to receive one of two doses of EVI-01 or an existing treatment, and researchers tracked their symptoms over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- hyaluronic acid injection (EVI-01)
- What this could lead to
- If successful, this could provide a new option for easing knee osteoarthritis pain and stiffness with a single injection.
- What could go wrong
- This is a small, early dose-finding study, so results may not confirm effectiveness. The treatment only targets symptoms, not the underlying disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A2Z Clinical
Valinhos, São Paulo, Brazil
-
Ortocity
São Paulo, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can discarded bone reveal the secrets to stronger bones?
- Could a common painkiller sabotage your knee treatment?
- Can a new shoulder implant restore Pain-Free movement?
- Can a less invasive hip surgery speed up recovery?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Can a Mind-Body program ease knee pain and lift mood?